Formycon Appoints Development and Production Expert Thomas Siklosi to the Advisory Board
The biosimilars company Formycon (ISIN: DE000A1EWVY8/ WKN: A1EWVY) is appointing Thomas Siklosi, a former board member o…
The biosimilars company Formycon (ISIN: DE000A1EWVY8/ WKN: A1EWVY) is appointing Thomas Siklosi, a former board member o…
Das Biosimilarunternehmen Formycon (ISIN: DE000A1EWVY8/ WKN: A1EWVY) beruft Thomas Siklosi, ehemaliger Vorstand der Ren…
Das Laupheimer Familienunternehmen, das als Contract Manufacturing Organisation für seine internationalen Kunden biophar…
The family-owned business based in Laupheim has expanded its management board. As a contract manufacturing organization,…
Rentschler Biotechnologie GmbH, a full-service contract biomanufacturing company, is pleased to announce that the compan…
Im Rahmen des internationalen Sonderprojekts „Finanzplätze 2008“ analysiert ein Team aus fünf hochqualifizierten Studier…